|
RNF10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.170000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.477600E-01 |
| Normal-vs-Stage2 |
2.515900E-02 |
| Normal-vs-Stage3 |
1.204020E-01 |
| Normal-vs-Stage4 |
1.285200E-01 |
| Stage1-vs-Stage2 |
3.292100E-02 |
| Stage1-vs-Stage3 |
1.620020E-02 |
| Stage1-vs-Stage4 |
4.738400E-02 |
| Stage2-vs-Stage3 |
9.751200E-04 |
| Stage2-vs-Stage4 |
1.316530E-03 |
| Stage3-vs-Stage4 |
9.418000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.397600E-01 |
| Normal-vs-AfricanAmerican |
7.544200E-01 |
| Normal-vs-Asian |
7.121400E-01 |
| Caucasian-vs-AfricanAmerican |
6.695400E-01 |
| Caucasian-vs-Asian |
4.399000E-01 |
| AfricanAmerican-vs-Asian |
9.645000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.323600E-01 |
| Normal-vs-Female |
6.976600E-01 |
| Male-vs-Female |
6.534300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.036000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.559800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.853400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.075200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.298000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.955900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.705600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.440800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.092000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.382600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.338200E-03 |
| Classical-VS-Follicular |
6.787700E-02 |
| Classical-VS-Other |
9.199800E-01 |
| Classical-VS-Normal |
8.207200E-01 |
| Tall-VS-Follicular |
4.44250000000146E-05 |
| Tall-VS-Other |
1.068830E-01 |
| Tall-VS-Normal |
2.302200E-03 |
| Follicular-VS-Other |
5.155600E-01 |
| Follicular-VS-Normal |
8.128300E-02 |
| Other-VS-Normal |
9.737200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.695200E-01 |
| Normal-vs-N1 |
1.584390E-02 |
| N0-vs-N1 |
4.936500E-03 |
|
|
